Literature DB >> 18424159

Low frequency of HLA-B27 in ankylosing spondylitis patients from Turkey.

Esen Kasapoglu Gunal1, Fatma Oguz Sarvan, Sevil Kamali, Ahmet Gul, Murat Inanc, Mahmut Carin, Meral Konice, Orhan Aral, Lale Ocal.   

Abstract

OBJECTIVES: Ankylosing spondylitis is strongly associated with HLA-B27. However, the strength of the association with HLA-B27 and the clinical features may vary in different parts of the world. The aim of this study is to compare the clinical features of AS and the frequencies of HLA-B27 and its alleles in patients from Turkey with other series.
METHODS: One hundred and twelve patients (72 male/40 female) fulfilling the modified New York criteria for the classification of AS and 55 (27 male/28 female) healthy controls were typed for HLA-B27 and allele frequencies by sequence specific primer (PCR/SSP) method and assessed for clinical manifestations.
RESULTS: Male to female ratio was 1.8, mean age at disease onset was 23.5 and 24.1% of patients reported juvenile onset of symptoms. Peripheral arthritis was seen in 52.7% of patients. Family history (p=0.01) and peripheral arthritis (p=0.02) were more frequent in females and spinal involvement in males. HLA-B27 was found to be positive in 70% of patients and associated with younger mean age, uveitis and shorter time elapsed from symptom to diagnosis. The frequency of HLA-B27 alleles associated with SpA was not different between ankylosing spondylitis patients and healthy controls.
CONCLUSION: Low frequency of HLA-B27 and clinical variations in ankylosing spondylitis may be due to different genetic and/or environmental factors in Turkey.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18424159     DOI: 10.1016/j.jbspin.2007.06.021

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  18 in total

1.  A polymorphism in ERAP1 is associated with susceptibility to ankylosing spondylitis in a Turkish population.

Authors:  Muhammet Cinar; Hatice Akar; Sedat Yilmaz; Ismail Simsek; Mutlu Karkucak; Rahsan Ilıkci Sagkan; Aysel Pekel; Hakan Erdem; Ismail Yasar Avci; Cengizhan Acikel; Ugur Musabak; Yusuf Tunca; Salih Pay
Journal:  Rheumatol Int       Date:  2013-07-18       Impact factor: 2.631

2.  Evaluation of DNMT1 gene expression profile and methylation of its promoter region in patients with ankylosing spondylitis.

Authors:  Saeed Aslani; Mahdi Mahmoudi; Masoud Garshasbi; Ahmad Reza Jamshidi; Jafar Karami; Mohammad Hossein Nicknam
Journal:  Clin Rheumatol       Date:  2016-09-16       Impact factor: 2.980

Review 3.  Recent studies on the genetic basis of ankylosing spondylitis.

Authors:  John D Reveille
Journal:  Curr Rheumatol Rep       Date:  2009-10       Impact factor: 4.592

4.  Study of programmed cell death 1 (PDCD1) gene polymorphims in Iranian patients with ankylosing spondylitis.

Authors:  Narjes Soleimanifar; Ali Akbar Amirzargar; Mahdi Mahmoudi; Ali Akbar Pourfathollah; Esfandiar Azizi; Ahmad Reza Jamshidi; Nima Rezaei; Mohammad Taher Tahoori; Katayoon Bidad; Behrouz Nikbin; Mohammad Hossein Nicknam
Journal:  Inflammation       Date:  2011-12       Impact factor: 4.092

5.  Registry of the clinical characteristics of spondyloarthritis in a cohort of Egyptian population.

Authors:  M Y Tayel; E Soliman; W F El Baz; A El Labaan; Y Hamaad; M H Ahmed
Journal:  Rheumatol Int       Date:  2011-08-31       Impact factor: 2.631

6.  Evaluation of MIF -173 G/C Polymorphism in Turkish Patients with Ankylosing Spondylitis.

Authors:  Çevik Gürel; Ahmet İnanır; Ayşe Feyda Nursal; Akın Tekcan; Aydın Rüstemoğlu; Serbülent Yigit
Journal:  Balkan Med J       Date:  2016-11-01       Impact factor: 2.021

7.  HLA-B, DR and DQ antigens polymorphism in Tunisian patients with ankylosing spondylitis (a case-control study).

Authors:  Mohamed Montacer Kchir; Wafa Hamdi; Lilia Laadhar; Samir Kochbati; Dhia Kaffel; Kaouthar Saadellaoui; Houria Lahmar; Mohamed Mehdi Ghannouchi; Dhouha Azzouz; Lilia Daoud; Abdelmajid Ben Hamida; Béchir Zouari; Mondher Zitouni; Sondes Makni
Journal:  Rheumatol Int       Date:  2009-08-05       Impact factor: 2.631

8.  Prevalence of HLA-B27 in Moroccan healthy subjects and patients with ankylosing spondylitis and mapping construction of several factors influencing AS diagnosis by using multiple correspondence analysis.

Authors:  Amal Akassou; Hanae Yacoubi; Afaf Jamil; Nadia Dakka; Saaïd Amzazi; Khalid Sadki; Redouane Niamane; Selma Elhassani; Youssef Bakri
Journal:  Rheumatol Int       Date:  2015-08-07       Impact factor: 2.631

9.  Evaluation of the short-term efficacy of NSAIDs on patients with active ankylosing spondylitis in daily practice: a 3-month, longitudinal, observational study.

Authors:  Muhammet Cinar; Ayhan Dinc; Ismail Simsek; Hakan Erdem; Bayram Koc; Salih Pay; Selim Kilic
Journal:  Rheumatol Int       Date:  2009-05-23       Impact factor: 2.631

10.  Thoughts and perceptions of ankylosing spondylitis patients with regard to TNF inhibitors.

Authors:  Fatma Ilknur Cinar; Muhammet Cinar; Sedat Yilmaz; Ismail Simsek; Hakan Erdem; Salih Pay
Journal:  Rheumatol Int       Date:  2013-12-29       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.